These authors contributed equally. Abstract Different environmental factors, including diet, physical activity, or external conditions can contribute to genotype-environment interactions (GxE). Although high-dimensional environmental data are increasingly available, and multiple environments have been implicated with GxE at the same loci, multi-environment tests for GxE are not established.
Introduction
Increasingly large population cohorts that combine genetic profiling with deep phenotyping and environmental information, including diet, physical activity and other lifestyle covariates, have fostered interest to study genotype-environment interactions (GxE). Already, such analyses have identified GxE for human phenotypes, including disease risk 1, 2 , and molecular traits 3, 4 .
Established methods to detect GxE implement tests that evaluate the effect of a single environmental variable on individual genetic variants 5 . Recent multivariate extensions enable assessing GxE across sets of genetic variants, either using genetic risk scores 6 or variance component tests [7] [8] [9] .
Whilst there is evidence to suggest that multiple environments can interact with a single genetic locus to influence phenotypes, for example FTO interacts with a number of environments to alter BMI risk, including physical activity [10] [11] [12] [13] , diet [12] [13] [14] [15] and smoking 12 , there exist no robust methods for the joint GxE analysis of multiple environmental variables. Such joint tests may increase the power to detect GxE, in particular when GxE effects are simultaneously driven by multiple environments, while at the same time reducing the multiple testing burden. Additionally, joint models of multiple environmental variables can improve the interpretation of GxE effects, allowing to assess the relevance of individual environments. As increasingly high-dimensional environmental data are available in population cohorts, there is a growing need for multi-environment GxE tests.
Here, we present a robust multi-environment GxE test based on linear mixed models (LMMs), using a random effect component to jointly model the effect of multiple environmental variables. The method generalises previous GxE tests to enable the joint analysis of hundreds of environmental variables and can be applied to large cohorts of hundreds of thousands of individuals.
Results
Usually, LMMs test for persistent genetic associations of individual variants, that means constant genetic effect sizes across the population. Covariates and additional random effect components are included to account for population structure, environment, and other additive (confounding) factors. StructLMM extends the LMM framework by modelling heterogeneity in effect sizes due to GxE (1) .
Here, is a vector of per-individual effect sizes and follows a multivariate normal distribution (2) .
The first covariance term corresponds to a persistent genetic effect whereas the second covariance term accounts for heterogeneous effect sizes parameterised by an environmental covariance , where the parameter ρ defines the fraction of genetic variance due to GxE. Depending on the functional form of , this model can be used to account for different types of GxE, for example hierarchies of discrete environmental groups, or as considered here, GxE effects based on a set of continuous and discrete environmental covariates ( Fig. 1b-c) . The environmental covariance is also used to account for additive (i.e. non-genetic) environmental effects, ∼ (0, ). The model is technically related to existing random effect tests for rare variants 16 and epistasis 17 (Methods). (2)), and predicting per-individual genetic effect sizes based on environmental profiles in the population (Fig. 1d) . Finally, the model can be used to assess the relevance of individual environmental variables for GxE ( Fig. 1e) . The full derivation of our method can be found in Methods.
Figure 1 | Overview of the

Model validation using simulated data
Initially, we considered simulated data using genotypes from the 1000 Genomes project 18 First, we confirmed the statistical calibration of StructLMM, considering phenotypes simulated without any genetic effects (i.e. the null model) ( Fig. 2a, Supp. Fig. 1a ) or simulated from a persistent effect model without interactions (Supp. Fig. 1b ). Next, we simulated phenotypes with variable fractions of the genetic effects driven by GxE (ρ, Eq.
(2)), and assessed power of the StructLMM association test ( Fig. 2b) . For comparison, we also considered a conventional LMM that ignores GxE, as well as a two-degrees-of-freedom (2-df) fixed effect model to jointly test for persistent associations and interactions using single environments (similar to the 2-df test in Kraft et al. 5 ; Bonferroni adjusted for the overall number of environments, Methods). To facilitate direct comparisons, all considered models account for additive environmental effects using the same random effect term (Eq. (1)).
The power of the association tests decreased for larger GxE effects, demonstrating that strong GxE (large ρ) leads to reduced power for detecting associations (Fig. 2b) . We also assessed power of StructLMM and single-environment fixed effect tests (one degree of freedom, e.g. Gauderman et al. 19 ) for detecting GxE interactions based on the same data, where power increased for larger proportions of genetic variance due to GxE (Fig. 2c) .
Notably, both the StructLMM association and interaction tests were substantially better powered than existing methods, indicating that the model is broadly applicable to account for GxE. As a second parameter, we simulated phenotypes with increasing number of environments contributing to GxE effects, but tested for GxE effects using all 60 environmental variables. The results of this analysis show that StructLMM increasingly outperforms the corresponding single environment GxE model as the number of environments with non-zero GxE increases ( Fig. 2d, e ), in particular when testing for interaction effects ( Fig. 2e ). Fig. 2 ) and had consistent power advantages over alternative methods (Supp. Fig. 3 ). Finally, we note that multi-environment GxE tests can in principle also be implemented based on fixed effect tests with as many degrees of freedoms as environments. However, we observed that such tests were not always calibrated and had lower power in some settings (Supp. Fig. 4) ,
Figure 2 | Assessment of statistical calibration and power
demonstrating the advantages of the random effect approach taken in StructLMM.
Taken together, these results show increased power and robustness of StructLMM compared to existing methods, in particular when large numbers of environments drive the GxE interaction effects.
Application to data from UK Biobank
We tested for associations between low-frequency and common variants (imputed variants, MAF>1%, 7,515,856 variants in total) and BMI, considering 64 lifestyle covariates similar to those used in Young et al. 13 . 12 ). However, the distribution of ⍴ suggests substantial heterogeneity in genetic effect sizes for significant loci (Supp. Fig.   12 ), in particular for the 13 loci that were exclusively detected by StructLMM (Supp. Fig. 8-11 ) (0.23<⍴<0.94). Additionally, StructLMM yielded lower P values for associations recovered by both models (Fig. 3a, Fig. 7) .
Several of the additional loci identified by StructLMM have been previously associated to BMI or BMI-related traits. These included a variant (rs11259931) in ADAMTSL3, which codes for a glycoprotein 21 . The same variant and variants in LD (r 2 >0.53) have previously been linked to BMI-related traits, including lean body mass 22 , waist circumference 23 , hip circumference adjusted for BMI 24 and height 25 . A second example is rs11880064 in PEPD, which encodes for a protein involved in the final stage of degradation of endogenous and dietary proteins. Several additional PEPD genetic variants have been associated with adiponectin 26, 27 , fasting insulin adjusted for BMI 28 , HDL cholesterol 29 , triglycerides 29, 30 , type 2 diabetes 31 , waist circumference adjusted for body mass 24 and waist to hip ratio 24 . A third association (rs473428) was identified upstream of ONECUT1 and downstream of WDR72.
ONECUT1 stimulates the production of liver expressed genes and can inhibit glucocorticoidstimulated gene transcription 32 and genetic association with BMI 33 , cholesterol HDL 30 , lipids 30 and triglycerides 30 were reported in early GWAS results but have not reached genome-wide significance in more recent meta-analyses 34 , which may be due to GxE effects varying across the different aggregated cohorts or due to differences in trait transformation. Variants in WDR72 are also associated to a large of number of relevant traits 30, 33 . Next, we applied StructLMM to test for GxE interactions. To reduce the number of tests, we tested for interactions at 97 GIANT variants (corresponding genes as annotated by GIANT 34 ) that have previously been linked to BMI using independent data 34 . For comparison, we also applied a one degree of freedom fixed effect GxE test using individual environments (Fig.   3b, Supp. Fig. 7, Supp. Fig. 14, Supp. Supp. Fig. 14a ), which has previously been implicated with GxE for multiple environments 10,12-14 , MC4R (Fig. 3c) for which an interaction with physical activity in females aged 20-40yrs has been previously suggested (P-adj=0.025) 12 , SEC16B (Supp. Fig. 14b ), for which secondary analyses provided some evidence for an interaction (P=0.025) with physical activity in Europeans 11 and in a separate study in Hispanics 35 and PARK2 (Supp. Fig. 14c ), a gene that has been linked to time-dependent variation in BMI suggested to be due to changes of environmental exposures 36 . StructLMM also enhanced the significance of test for interactions identified by both models, with significance levels for FTO and SEC16B dropping from P=4.23x10 -16 to P-adj=6.76x10 -6 and P=1.15x10 -4 to P-adj=4.48x10 -4 respectively, when considering a single-environment test. Larger differences in the number of discoveries were observed for more lenient threshold, e.g. 11 versus six loci with GxE at 5% FDR (Benjamini-Hochberg adjusted, Supp. Table 3 ). Finally, we compared to a multi-environment GxE test based on fixed effects, which although calibrated on this large dataset, was underpowered (Sup. Fig. 15 ).
StructLMM can be used for the interpretation of GxE interactions, and in particular to predict per-individual genetic effects based on environmental profiles (Fig. 4a) . We assessed the consistency of these estimates using hold-out validation, confirming that StructLMM can be used to explain and predict inter-individual variations in genetic effects due to GxE (Supp. factors that contribute to the GxE effect at MC4R, including all three physical activity measures for females, in agreement with 12 , but also identified a number of additional environments (some of which were more relevant) ( Fig. 4c) , underlining the benefits of multivariate modelling of GxE using sets of environments.
For other loci, we consistently observed that multiple environments contribute to GxE but there are large differences in the GxE architecture, with FTO driven by the largest number of environments (approximately 35) whilst SEC16B and PARK2 were driven by a much smaller number of environments (approximately 9 and 10 respectively) (Supp. Fig. 14d-f) . We also note that many of the environmental effects were gender specific for MC4R and PARK2 and age dependent at SEC16B, with substantial overlap between the sets of interacting environments for three of the four loci, PARK2 being the exception. Differences in the environments that drive these GxE effects were also apparent when correlating effect size predictions across loci, which identified groups of variants with similar GxE profiles (Supp. 
Identification of eQTL interactions with cellular state
As a second application, we considered a gene expression dataset and used StructLMM to identify regulatory variants with genetic effects that depend on cellular contexts, such as cell type 37 or external stimuli 4 . The identification of such context-dependent genetic effects can help elucidate the regulatory mechanisms of disease loci by identifying relevant cell types and molecular pathways [38] [39] [40] .
We reanalyzed the large whole-blood expression dataset comprising of over 2,000 genotyped samples profiled with RNA-seq 41 (Methods) and investigated cell-context interactions of cis expression quantitative trait loci (eQTL). Following 41 , we considered gene expression levels both as phenotypes but also as proxy variables to capture inter-sample variation due to changes in blood cell composition and other factors. Specifically, we considered a set of 443 highly variable genes as environmental factors in our analysis (Methods).
Initially, we applied a standard LMM to map cis expression quantitative trait loci (eQTL, plus or minus 250 kb from the centre of the gene, Methods). Next, we applied StructLMM to test for cell-context interactions at lead variants for 23,277 genes with an eQTL (FDR<5%, Methods). This identified 3,483 eQTL with a cell-context interaction (FDR<5%, Supp. Fig. 18 ). Although overall, interactions with cell-context tended to explain only a small proportion of the cis genetic effect on gene expression variance ( < 0.2, for 68.0% of eQTL with a cell-context interaction, Fig. 5a ), our analysis identified 532 genes (15.3% of eQTL with cell-context interaction) for which heterogeneity explained a larger proportion of the cis genetic variance than persistent effects (ρ> 0 .5, Fig. 5a ). As alternative method to detect cell-context interactions, we also considered multi-environment interaction tests based on fixed effects (Methods), which were less robust and identified fewer interaction eQTL than StructLMM (Supp. Fig. 18 ). Finally, we compared our interaction results to the findings of the primary analysis of the data 41 , where a step-wise procedure was employed to identify interaction eQTL (Methods). For 17,952 genes that were analysed in both studies, StructLMM identified 3,372 interaction eQTL compared to 1,841 interaction eQTL in the primary analysis (overlap 1,071, FDR<5%, Supp. Fig. 18 ). Next, we overlapped eQTL with cell-context interactions and risk variants from the NHGRI-EBI GWAS catalog V1.0.1 42 , which identified 64 instances of putative colocalisation (r 2 >0.8
of lead eQTL and GWAS variants, Methods), including GWAS variants for autoimmune diseases, infectious diseases and blood cell traits (Supp. Notably, 46 of these eQTL with interactions were not reported in the primary analysis 41 . One of these is an interaction eQTL for CTSW expression (Fig. 5c, P=2 .2x10 -15 , ρ=0.12), which is in LD with a risk variant for Crohn's disease rs568617 (r 2 =1.00, Supp. Fig. 19) . To investigate the molecular pathways that drive this interaction eQTL, we stratified the population into groups with increased/decreased genetic effects predicted using StructLMM, and tested for enriched pathways among genes that were differentially expressed between these groups (Methods). This identified positive T cell selection (GO:0046632) and positive regulation of interleukin-17 secretion (GO:0032740) as cell-context environments that underlie the interaction eQTL (See Supp. 
Discussion
We proposed a method based on LMMs to flexibly model GxE using sets of environments, thereby enabling the analysis of genotype-environment interactions with multiple environments. Conceptually, our approach is related to set tests for groups of variants, and offers power advantages when multiple environmental factors contribute to GxE (Fig. 2) .
We applied StructLMM to data from UK Biobank, where the model detected association signals that were missed by an LMM, in particular when a substantial fraction of the genetic variance was explained by GxE. This demonstrates that accounting for heterogeneity in effect sizes (GxE) is not only of interest for mechanistic characterization of known genetic effects across environments, but can in some instances also increase the power to detect new genetic effects, which is similar to previous uses of 2-df fixed effect tests 5 .
When assessing GxE at 97 GIANT variants associated with BMI, we confirm established GxE effects for FTO, and we identified, for the first time, three additional GxE signals at stringent thresholds, some of which confirm prior evidence 11, 12, 14, 15, 35, 36 . FDR-based significance, as frequently employed for GxE analyses 6, 12 , would increase the number of discoveries further, yielding up to 11 GIANT variants with evidence for GxE on BMI (Supp. Table 2 ). In addition to offering power advantages, StructLMM yields per-individual predictions of variation in genetic effects due to GxE. We have shown that this allows for important downstream analyses, including the identification of individuals with increased or decreased genetic effects at different loci based on their own environmental exposure, and the identification of environmental factors that drive GxE.
As a second use case, we applied StructLMM to test for cell-context interactions in a large blood eQTL study. The same modelling principles enabled the identification of contextspecific eQTL. Several of these interaction eQTL colocalised with GWAS variants and the marker genes of the cellular environment that underlie these GxE effects could be connected to plausible biological processes. This analysis also confirms that StructLMM can be robustly applied to analyse interaction effects driven by large numbers of environments.
Although we found that StructLMM is a robust alternative to conventional linear interaction tests, the model is not free of limitations. First, while the computational complexity of the model scales linearly with the number of individuals, thereby enabling genome-wide analyses of large cohorts, its application remains computationally more demanding than conventional LMMs. A second area for future developments is the selection of variants for GxE tests. To mitigate the cost of multiple testing, we have considered variants that have been associated with the phenotype in other studies. However, the fact that our association tests identifies novel loci if applied genome-wide suggests that this filter is not optimal.
Finally, while StructLMM can in principle be used in conjunction with any environmental covariance, we have here limited the application to linear covariances. The model could be extended to account for non-linear interactions, for example using polynomial covariance functions. Such developments are a future area of work, in particular as increasingly large cohorts allow for detecting such higher order interaction effects.
Availability of code and data. StructLMM is available from https://github.com/limix/structlmm and is supported within the LIMIX framework at https://github.com/limix/limix. For tutorials and illustrations on how to use the model, see http://struct-lmm.readthedocs.io. The BIOS RNA data can be obtained from the European Genome-phenome Archive (EGA; accession/EGAS00001001077). Genotype data are available from the respective biobanks.
